- Home
- ENOV vs JANX Comparison
ENOV vs JANX Comparison
Compare ENOV & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENOV
- JANX
- Stock Information
- Founded
- ENOV 1995
- JANX 2017
- Country
- ENOV United States
- JANX United States
- Employees
- ENOV N/A
- JANX N/A
- Industry
- ENOV Fluid Controls
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- ENOV Industrials
- JANX Health Care
- Exchange
- ENOV Nasdaq
- JANX Nasdaq
- Market Cap
- ENOV 2.1B
- JANX 2.2B
- IPO Year
- ENOV 2008
- JANX 2021
- Fundamental
- Price
- ENOV $38.21
- JANX $27.37
- Analyst Decision
- ENOV Buy
- JANX Strong Buy
- Analyst Count
- ENOV 4
- JANX 8
- Target Price
- ENOV $58.50
- JANX $91.25
- AVG Volume (30 Days)
- ENOV 952.0K
- JANX 833.0K
- Earning Date
- ENOV 05-01-2025
- JANX 05-06-2025
- Dividend Yield
- ENOV N/A
- JANX N/A
- EPS Growth
- ENOV N/A
- JANX N/A
- EPS
- ENOV N/A
- JANX N/A
- Revenue
- ENOV $2,107,623,000.00
- JANX $10,588,000.00
- Revenue This Year
- ENOV $7.09
- JANX N/A
- Revenue Next Year
- ENOV $6.38
- JANX $318.21
- P/E Ratio
- ENOV N/A
- JANX N/A
- Revenue Growth
- ENOV 23.45
- JANX 30.99
- 52 Week Low
- ENOV $35.14
- JANX $28.91
- 52 Week High
- ENOV $62.79
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- ENOV 43.35
- JANX 31.39
- Support Level
- ENOV $38.51
- JANX $29.77
- Resistance Level
- ENOV $40.70
- JANX $32.00
- Average True Range (ATR)
- ENOV 1.33
- JANX 1.53
- MACD
- ENOV 0.26
- JANX 0.14
- Stochastic Oscillator
- ENOV 49.87
- JANX 17.88
About ENOV Enovis Corporation
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.